SIC
DNA icon

SJS Investment Consulting’s Ginkgo Bioworks DNA Stock Holding History

SJS Investment Consulting’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69K Buy
170
+154
+963% +$1.29K ﹤0.01% 1844
2026
Q1 		$99 Buy
+16
New +$133 ﹤0.01% 2135
2024
Q1 		– Sell
-13
Closed -$845 – 1661
2023
Q4 		$845 Buy
+13
New +$796 ﹤0.01% 1022

Other funds holding DNA

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SJS Investment Consulting's DNA Position: Q2 2026 in Review

SJS Investment Consulting increased its Ginkgo Bioworks (DNA) stake by 963% in Q2 2026, buying an estimated $1.29K and bringing the position to 170 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

SJS Investment Consulting first reported a position in DNA in Q4 2023 and has held it in 3 quarters since. 37 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • SJS Investment Consulting held 170 shares of Ginkgo Bioworks worth $1.69K as of Q2 2026.
  • SJS Investment Consulting bought 154 Ginkgo Bioworks shares in Q2 2026, an estimated $1.29K.
  • Ginkgo Bioworks made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1844 holding.
  • SJS Investment Consulting first reported a position in Ginkgo Bioworks in Q4 2023 and has held it in 3 quarters since.
  • 37 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.